Eirgen Pharma

We are a research-driven company that specialises in the development, manufacture and supply of a broad range of High Potency Oral Solid Dose (OSD) Human & Veterinary speciality products. Since 2006, we have built a reputation as an innovative company specialising in developing and manufacturing of film-coated tablets, soft-gel capsules, and powder or liquid-filled hard-shell capsules. Our work, which focused on successfully producing cancer chemotherapy drugs, allowed us to create strong partnerships with leading pharmaceutical companies, thus making our founders vision a reality. In 2015, our successful track record and reputation for industry excellence prompted the acquisition of Eirgen Pharma...

High potency pharmaceutical products,oncology & cytotoxic products,ema,fda & pmda approved facility,high containment product development & manufacture,sterile fill finish,microbiology,global supply chain,and research & development

Eirgen pharma operates in the Pharmaceutical manufacturing industry.

Eirgen pharma's revenue is 11m - 100m

Eirgen pharma has 51 - 200 employees.